Back to UNH Overview
NYQ · Valuation Lab
UNH
UnitedHealth Group Incorporated
Last$412.75
Market cap374.8B
EV/EBITDA17.3x
Intrinsic value
$483.35
MoS +14.6% · Fairly Valued
Assuming 5.1% FCF margin and 0.4% Y1–5 growth.
Upside to price
EV (DCF)480.8B
Terminal share65%
Expected IV$552.87
Probability weights
Projected free cash flows
Stage FCF path with present values · terminal 65% of EV
PV of stage FCFs168.7B
PV of terminal value312.1B
Enterprise value480.8B
Net cash / (debt)-41.9B
Equity value438.9B
Intrinsic value / share$483.35
| Year | Revenue | FCF | PV | DF |
|---|---|---|---|---|
| Y1 | 451.9B | 23B | 21.6B | 93.6% |
| Y2 | 453.7B | 23.1B | 20.3B | 87.6% |
| Y3 | 455.6B | 23.2B | 19B | 81.9% |
| Y4 | 457.4B | 23.3B | 17.9B | 76.7% |
| Y5 | 459.2B | 23.4B | 16.8B | 71.7% |
| Y6 | 468.4B | 23.9B | 16B | 67.1% |
| Y7 | 477.8B | 24.4B | 15.3B | 62.8% |
| Y8 | 487.3B | 24.9B | 14.6B | 58.8% |
| Y9 | 497.1B | 25.3B | 13.9B | 55.0% |
| Y10 | 507B | 25.9B | 13.3B | 51.5% |
| Terminal | — | — | 312.1B | — |
Educational DCF model only — not financial advice. Terminal value and assumptions dominate results; verify filings and run your own diligence.